Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 2 |
2024 | 4 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States.
Aliment Pharmacol Ther. 2024 Jun;59(12):1571-1578. doi: 10.1111/apt.17997. Epub 2024 Apr 8.
Aliment Pharmacol Ther. 2024.
PMID: 38586922
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.
Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R.
Noureddin N, et al.
Aliment Pharmacol Ther. 2023 Nov;58(9):856-865. doi: 10.1111/apt.17707. Epub 2023 Sep 11.
Aliment Pharmacol Ther. 2023.
PMID: 37694993
Item in Clipboard
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R.
Lee SW, et al.
Aliment Pharmacol Ther. 2024 Jan;59(1):80-88. doi: 10.1111/apt.17783. Epub 2023 Nov 15.
Aliment Pharmacol Ther. 2024.
PMID: 37968251
Free PMC article.
Item in Clipboard
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Ajmera V, Liu A, Bettencourt R, Dhar D, Richards L, Loomba R.
Ajmera V, et al.
Aliment Pharmacol Ther. 2021 Jul;54(1):68-77. doi: 10.1111/apt.16392. Epub 2021 May 11.
Aliment Pharmacol Ther. 2021.
PMID: 33975381
Free PMC article.
Item in Clipboard
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R.
Noureddin N, et al.
Aliment Pharmacol Ther. 2024 Jun;59(12):1521-1526. doi: 10.1111/apt.17981. Epub 2024 Apr 3.
Aliment Pharmacol Ther. 2024.
PMID: 38571305
Item in Clipboard
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes.
Bridi L, Agrawal S, Tesfai K, Madamba E, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V.
Bridi L, et al.
Aliment Pharmacol Ther. 2024 Jun 2. doi: 10.1111/apt.18099. Online ahead of print.
Aliment Pharmacol Ther. 2024.
PMID: 38825972
Item in Clipboard
Cite
Cite